Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.1B | 976M | 1.1B | 894M |
Cost of revenue | 630M | 522M | 544M | 547M |
Gross profit | 498M | 454M | 537M | 347M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | 60M |
Operating income | 257M | 221M | 313M | 130M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 119M | 120M | 114M | 108M |
Other income expense | 28M | 18M | 34M | 32M |
Pretax income | 166M | 140M | 233M | 54M |
Tax provision | -47M | -10M | -62M | -33M |
Net income | 213M | 150M | 295M | 87M |
Basic EPS | 0.8 | 0.6 | 1.2 | 0.3 |
Diluted EPS | 0.8 | 0.6 | 1.2 | 0.3 |
Basic average shares | 256.8M | 256.6M | 256.6M | 256.4M |
Diluted average shares | 257.2M | 257.2M | 256.9M | 256.7M |
EBITDA | 478M | 465M | 522M | 331M |
Net income from continuing op. | 213M | 150M | 295M | 87M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |